BioSpace News Archive

Business

Medicure Q3 2018 Results and Conference Call Dates

Medicure Inc. (“Medicure”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended September 30, 2018 on Tuesday, November 20, 2018.

November 14, 2018
·
1 min read
Business

INVO Bioscience Reports Record Third Quarter 2018 Financial Results

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced its Q3 2018 financial results or the quarter ended September 30, 2018 and recent highlights.

November 14, 2018
·
7 min read
Business

Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2018, and provided an update on its business.

November 14, 2018
·
8 min read
Business

Neovasc Announces Third Quarter 2018 Financial Results

FDA has granted Breakthrough Device designation to the Neovasc Reducer™ (the “Reducer”) for the treatment of refractory angina

November 14, 2018
·
27 min read
Business

Leading Medical Cannabis Company Surterra Wellness Announces Beau Wrigley as New CEO

Surterra Wellness Expanded from 100 to over 500 Employees in 2018

November 14, 2018
·
2 min read
Drug Development

Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline

Trial Initiation Demonstrates Rapid Progress Since Company Launch

November 14, 2018
·
3 min read
Policy

Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

The jury unanimously found that all Single Cell and Linked-Read genomics products sold by 10X Genomics willfully infringed the patents owned by the University of Chicago and licensed to Bio-Rad.

November 14, 2018
·
3 min read
Business

DrugTestingCourses.com’s Reasonable Suspicion Training Course Safeguards DOT-Regulated Employers

Easler Education has developed its most recent version of reasonable suspicion training in order to accommodate both DOT regulatory requirements and modern Congressional concerns over new synthetic opioids and the American opioid epidemic.

November 14, 2018
·
3 min read
Business

Perlara announces Leigh syndrome PerlQuest partnership with Radical Investments

Radical Investments is the venture capital firm of serial entrepreneur and impact investor Mark Cuban.

November 14, 2018
·
3 min read
Business

Abyrx® Appoints Gary D. Cohn as Director

Former Director of the U.S. National Economic Council and Goldman Sachs COO joins biomaterial sciences company Board of Directors

November 14, 2018
·
3 min read